metaLead Therapeutics secured CHF 1 million in funding from the UZH Life Sciences Fund (LSF)
01 May 2025
01 May 2025
Total investments received (USD): 1.07M
Round value (USD): 1.07M
Round investors: UZH Life Sciences Fund
Company: metaLead Therapeutics
Industry: Health servicesPharma
Related deals
FluoSphera raised CHF 1.15 million led by Soulmates Ventures and a Swiss business angel, with participation from IndieBio New York.
Investments
12 December 2025
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom